Stockreport

Halozyme cut to Neutral at J.P. Morgan on valuation [Seeking Alpha]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF Morgan downgraded the developer of Enhanze drug delivery technology to neutral from overweight, arguing that the stock is fully valued at current levels. However, anal [Read more]